» Articles » PMID: 32954447

Validation of Multiparametric MRI by Histopathology After Nephrectomy: a Case Study

Abstract

Objectives: Renal multiparametric MRI (mpMRI) is a promising tool to monitor renal allograft health to enable timely treatment of chronic allograft nephropathy. This study aims to validate mpMRI by whole-kidney histology following transplantectomy.

Materials And Methods: A patient with kidney transplant failure underwent mpMRI prior to transplantectomy. The mpMRI included blood oxygenation level-dependent (BOLD) MRI, T and T mapping, diffusion-weighted imaging (DWI), 2D phase contrast (2DPC) and arterial spin labeling (ASL). Parenchymal mpMRI measures were compared to normative values obtained in 19 healthy controls. Differences were expressed in standard deviations (SD) of normative values. The mpMRI measures were compared qualitatively to histology.

Results: The mpMRI showed a heterogeneous parenchyma consistent with extensive interstitial hemorrhage on histology. A global increase in T (+ 3.0 SD) and restricted diffusivity (- 3.6 SD) were consistent with inflammation and fibrosis. Decreased T (- 1.8 SD) indicated fibrosis or hemorrhage. ASL showed diminished cortical perfusion (- 2.9 SD) with patent proximal arteries. 2DPC revealed a 69% decrease in renal perfusion. Histological evaluation showed a dense inflammatory infiltrate and fibrotic changes, consistent with mpMRI results. Most interlobular arteries were obliterated while proximal arteries were patent, consistent with ASL findings.

Discussion: mpMRI findings correlated well with histology both globally as well as locally.

Citing Articles

Contemporary and Emerging MRI Strategies for Assessing Kidney Allograft Complications: Arterial Stenosis and Parenchymal Injury, From the Special Series on Imaging of Fibrosis.

Bane O, Lewis S, Lim R, Carney B, Shah A, Fananapazir G AJR Am J Roentgenol. 2023; 222(3):e2329418.

PMID: 37315018 PMC: 11006565. DOI: 10.2214/AJR.23.29418.

References
1.
Abecassis M, Bartlett S, Collins A, Davis C, Delmonico F, Friedewald J . Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol. 2008; 3(2):471-80. PMC: 2390948. DOI: 10.2215/CJN.05021107. View

2.
Josephson M . Monitoring and managing graft health in the kidney transplant recipient. Clin J Am Soc Nephrol. 2011; 6(7):1774-80. DOI: 10.2215/CJN.01230211. View

3.
Brachemi S, Bollee G . Renal biopsy practice: What is the gold standard?. World J Nephrol. 2014; 3(4):287-94. PMC: 4220363. DOI: 10.5527/wjn.v3.i4.287. View

4.
Selby N, Blankestijn P, Boor P, Combe C, Eckardt K, Eikefjord E . Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA. Nephrol Dial Transplant. 2018; 33(suppl_2):ii4-ii14. PMC: 6106645. DOI: 10.1093/ndt/gfy152. View

5.
Bane O, Hectors S, Gordic S, Kennedy P, Wagner M, Weiss A . Multiparametric magnetic resonance imaging shows promising results to assess renal transplant dysfunction with fibrosis. Kidney Int. 2019; 97(2):414-420. PMC: 6983343. DOI: 10.1016/j.kint.2019.09.030. View